ABBV analyst scorecard · AbbVie
64 rating changes on ABBV in the last 12 months. 65% of bullish calls were right at 30 days. Street grade B on 54 scored calls. Consensus target $277, 6% above the last close.
Graded through 2026-09-14 · last close $261.73 (2026-09-14). Rebuilt every morning.
Street grade
B 66.7%
Rating changes, 12 mo
64
Bullish calls right at 30d
65.4% of 52
Bearish calls right at 30d
—
Consensus target
$277 +6.0%
Firms covering
29
Price targets hit (90d)
34.3% of 35
Holds on ABBV, read: 2 cut to or raised to Hold (graded as the change) · 1 Holds whose target leaned 10%+ one way (graded that way) · 7 true Holds, not graded.
The 4 upgrades on ABBV came after an average +0.7% move in the prior 30 days, and the stock averaged +1.1% in the 90 days after.
Firm by firm
| Firm | Calls | Scored | Right | Accuracy | Grade | Avg 30d | Avg 90d | Latest | Date | Target |
|---|---|---|---|---|---|---|---|---|---|---|
| Evercore ISI Group | 5 | 5 | 5 | 100.0% | A | +3.5% | +8.2% | Outperform | 2026-08-10 | $260 |
| Canaccord Genuity | 5 | 5 | 5 | 100.0% | A | +5.2% | +24.1% | Buy | 2026-08-03 | $290 |
| Morgan Stanley | 4 | 4 | 3 | 75.0% | A | +2.5% | +6.4% | Overweight | 2026-08-03 | $296 |
| Piper Sandler | 7 | 6 | 4 | 66.7% | B | +1.6% | +7.8% | Overweight | 2026-08-20 | $303 |
| Guggenheim | 5 | 5 | 3 | 60.0% | B | +1.4% | +12.3% | Buy | 2026-08-04 | $288 |
| Cantor Fitzgerald | 6 | 6 | 3 | 50.0% | C | -0.3% | +12.7% | Overweight | 2026-08-03 | $285 |
| Citigroup | 3 | 1 | 1 | — | — | +3.7% | -2.7% | Neutral | 2026-07-15 | $260 |
| Wolfe Research | 2 | 2 | 2 | — | — | +2.0% | -5.6% | Outperform | 2026-08-13 | $300 |
| Berenberg | 2 | 2 | 2 | — | — | +3.0% | +1.3% | Buy | 2026-08-06 | $275 |
| Erste Group | 1 | 1 | 1 | — | — | +4.2% | — | Buy | 2026-08-05 | — |
| TD Cowen | 1 | 1 | 1 | — | — | +2.2% | — | Buy | 2026-07-31 | $280 |
| William Blair | 1 | 1 | 1 | — | — | +2.2% | — | Buy | 2026-07-31 | — |
| BMO Capital | 1 | 1 | 1 | — | — | +0.3% | — | Outperform | 2026-07-13 | $300 |
| Raymond James | 1 | 1 | 1 | — | — | +1.9% | -5.6% | Outperform | 2025-10-17 | $250 |
| JPMorgan | 3 | 3 | 2 | — | — | +4.2% | +5.8% | Overweight | 2026-07-09 | $280 |
| HSBC | 3 | 2 | 1 | — | — | -6.5% | -2.6% | Buy | 2026-09-10 | $315 |
| UBS | 3 | 0 | 0 | — | — | +2.0% | -3.2% | Neutral | 2026-07-13 | $260 |
| Wells Fargo | 2 | 1 | 0 | — | — | -0.0% | — | Overweight | 2026-08-17 | $300 |
| Barclays | 2 | 2 | 0 | — | — | -5.9% | -4.6% | Overweight | 2026-07-29 | $300 |
| Bank of America | 2 | 1 | 0 | — | — | -4.7% | -2.0% | Buy | 2026-07-10 | $276 |
| RBC Capital | 2 | 2 | 0 | — | — | -3.9% | -6.1% | Outperform | 2026-07-10 | $280 |
| Freedom Broker | 2 | 2 | 0 | — | — | -7.8% | -7.3% | Buy | 2026-02-17 | $260 |
| BNP Paribas | 1 | 0 | 0 | — | — | +2.0% | — | Neutral | 2026-08-11 | $247 |
Dimmed rows have fewer than 4 scored calls on ABBV — too few to grade.
Every call, last 12 months
| Date | Firm | Change | Action | Graded as | Price at call | Run before | +30d | +60d | +90d | Target · 90d check | Hit |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-10 | HSBC | Buy → Buy | maintained | Bullish | $255.00 | +2.0% | — | — | — | $315 | pending |
| 2026-08-20 | Piper Sandler | Overweight → Overweight | maintained | Bullish | $261.83 | +2.2% | — | — | — | $303 | pending |
| 2026-08-17 | Wells Fargo | Overweight → Overweight | maintained | Bullish | $250.33 | -1.6% | — | — | — | $300 | pending |
| 2026-08-13 | Wolfe Research | Peer Perform → Outperform | upgrade | Bullish | $250.82 | +2.5% | +4.3% | — | — | $300 | ✓ |
| 2026-08-11 | BNP Paribas | Neutral → Neutral | maintained | True hold · target -1% | $250.09 | +0.8% | +2.0% | — | — | $247 | not graded |
| 2026-08-10 | Evercore ISI Group | Outperform → Outperform | maintained | Bullish | $247.97 | -0.0% | +1.2% | — | — | $260 | ✓ |
| 2026-08-06 | Berenberg | Buy → Buy | maintained | Bullish | $243.87 | -4.2% | +2.0% | — | — | $275 | ✓ |
| 2026-08-05 | Erste Group | Hold → Buy | upgrade | Bullish | $246.20 | -3.4% | +4.2% | — | — | — | ✓ |
| 2026-08-04 | Guggenheim | Buy → Buy | maintained | Bullish | $243.80 | -6.6% | +6.7% | — | — | $288 | ✓ |
| 2026-08-03 | Canaccord Genuity | Buy → Buy | maintained | Bullish | $245.10 | -6.1% | +6.8% | — | — | $290 | ✓ |
| 2026-08-03 | Cantor Fitzgerald | Overweight → Overweight | maintained | Bullish | $245.10 | -6.1% | +6.8% | — | — | $285 | ✓ |
| 2026-08-03 | Morgan Stanley | Overweight → Overweight | maintained | Bullish | $245.10 | -6.1% | +6.8% | — | — | $296 | ✓ |
| 2026-07-31 | TD Cowen | Buy → Buy | maintained | Bullish | $250.94 | -0.1% | +2.2% | — | — | $280 | ✓ |
| 2026-07-31 | William Blair | Buy → Buy | maintained | Bullish | $250.94 | -0.1% | +2.2% | — | — | — | ✓ |
| 2026-07-29 | Barclays | Overweight → Overweight | maintained | Bullish | $263.30 | +3.5% | -3.0% | — | — | $300 | ✗ |
| 2026-07-22 | Canaccord Genuity | Buy → Buy | maintained | Bullish | $253.30 | +10.1% | +4.6% | — | — | $282 | ✓ |
| 2026-07-15 | Citigroup | Neutral → Neutral | maintained | True hold · target +6% | $244.11 | +10.2% | +2.2% | +7.2% | — | $260 | not graded |
| 2026-07-13 | UBS | Neutral → Neutral | maintained | True hold · target +4% | $248.00 | +8.9% | +0.3% | +3.7% | — | $260 | not graded |
| 2026-07-13 | BMO Capital | Outperform → Outperform | maintained | Bullish | $248.00 | +8.9% | +0.3% | +3.7% | — | $300 | ✓ |
| 2026-07-10 | Bank of America | Buy → Buy | maintained | Bullish | $248.08 | +10.3% | -0.0% | +0.3% | — | $276 | ✗ |
| 2026-07-10 | RBC Capital | Outperform → Outperform | maintained | Bullish | $248.08 | +10.3% | -0.0% | +0.3% | — | $280 | ✗ |
| 2026-07-10 | Wells Fargo | Overweight → Overweight | maintained | Bullish | $248.08 | +10.3% | -0.0% | +0.3% | — | $295 | ✗ |
| 2026-07-09 | Guggenheim | Buy → Buy | maintained | Bullish | $249.91 | +10.9% | -0.8% | -0.5% | — | $261 | ✗ |
| 2026-07-09 | JPMorgan | Overweight → Overweight | maintained | Bullish | $249.91 | +10.9% | -0.8% | -0.5% | — | $280 | ✗ |
| 2026-07-06 | Cantor Fitzgerald | Overweight → Overweight | maintained | Bullish | $254.76 | +12.1% | -3.4% | +0.7% | — | $265 | ✗ |
| 2026-06-23 | Piper Sandler | Overweight → Overweight | reiterated | Bullish | $234.76 | +8.8% | +9.4% | +12.7% | — | $298 | ✓ |
| 2026-06-23 | Canaccord Genuity | Buy → Buy | maintained | Bullish | $234.76 | +8.8% | +9.4% | +12.7% | — | $273 | ✓ |
| 2026-05-15 | Evercore ISI Group | Outperform → Outperform | maintained | Bullish | $210.39 | +0.9% | +5.3% | +16.4% | +19.2% | $235 hit | ✓ |
| 2026-05-14 | Piper Sandler | Overweight → Overweight | maintained | Bullish | $210.77 | +0.2% | +5.1% | +17.7% | +18.0% | $298 missed | ✓ |
| 2026-05-04 | Evercore ISI Group | Outperform → Outperform | maintained | Bullish | $208.16 | -0.3% | +4.3% | +22.4% | +17.8% | $236 hit | ✓ |
| 2026-05-01 | Guggenheim | Buy → Buy | reiterated | Bullish | $206.60 | -3.9% | +3.1% | +21.8% | +24.6% | $249 hit | ✓ |
| 2026-04-30 | Canaccord Genuity | Buy → Buy | maintained | Bullish | $211.32 | -2.8% | +0.8% | +20.3% | +24.6% | $265 hit | ✓ |
| 2026-04-30 | Morgan Stanley | Overweight → Overweight | maintained | Bullish | $211.32 | -2.8% | +0.8% | +20.3% | +24.6% | $278 close | ✓ |
| 2026-04-30 | Cantor Fitzgerald | Overweight → Overweight | reiterated | Bullish | $211.32 | -2.8% | +0.8% | +20.3% | +24.6% | $240 hit | ✓ |
| 2026-04-23 | Piper Sandler | Overweight → Overweight | maintained | Bullish | $200.95 | -2.1% | +6.1% | +14.5% | +26.1% | $294 close | ✓ |
| 2026-04-21 | Canaccord Genuity | Buy | initiated | Bullish | $205.12 | +0.0% | +4.6% | +12.1% | +23.5% | $262 hit | ✓ |
| 2026-04-10 | Guggenheim | Buy → Buy | maintained | Bullish | $207.94 | -8.7% | -2.5% | +8.4% | +20.2% | $249 hit | ✗ |
| 2026-04-08 | Cantor Fitzgerald | Overweight → Overweight | maintained | Bullish | $211.59 | -7.0% | -4.8% | +5.4% | +20.4% | $240 hit | ✗ |
| 2026-02-25 | RBC Capital | Outperform | initiated | Bullish | $226.92 | +2.8% | -7.7% | -13.0% | -6.1% | $260 missed | ✗ |
| 2026-02-20 | Barclays | Overweight | initiated | Bullish | $224.81 | +4.0% | -8.8% | -8.8% | -4.6% | $275 missed | ✗ |
| 2026-02-18 | Piper Sandler | Overweight → Overweight | maintained | Bullish | $228.72 | +6.7% | -10.3% | -10.9% | -6.5% | $299 missed | ✗ |
| 2026-02-17 | Freedom Broker | Buy → Buy | maintained | Bullish | $232.86 | +8.6% | -11.4% | -12.5% | -10.1% | $260 missed | ✗ |
| 2026-02-05 | UBS | Neutral → Neutral | maintained | True hold · target +5% | $219.02 | -2.2% | +3.9% | -5.6% | -6.4% | $230 missed | not graded |
| 2026-02-05 | Evercore ISI Group | Outperform → Outperform | maintained | Bullish | $219.02 | -2.2% | +3.9% | -5.6% | -6.4% | $228 missed | ✓ |
| 2026-02-05 | Morgan Stanley | Overweight → Overweight | maintained | Bullish | $219.02 | -2.2% | +3.9% | -5.6% | -6.4% | $270 missed | ✓ |
| 2026-01-27 | Citigroup | Neutral → Neutral | maintained | True hold · target +2% | $223.93 | -2.6% | +0.3% | -4.8% | -11.9% | $230 missed | not graded |
| 2026-01-08 | Wolfe Research | Outperform → Peer Perform | downgrade | Bearish · cut to Peer Perform | $224.13 | +0.5% | -0.4% | +1.5% | -5.6% | — | ✓ |
| 2025-12-12 | Morgan Stanley | Overweight → Overweight | maintained | Bullish | $223.32 | -4.2% | -1.5% | -0.4% | +0.9% | $269 missed | ✗ |
| 2025-12-10 | HSBC | Hold → Buy | upgrade | Bullish | $225.18 | +3.0% | -2.3% | -0.8% | +0.8% | $265 missed | ✗ |
| 2025-11-12 | Freedom Broker | Buy → Buy | maintained | Bullish | $233.23 | +1.3% | -4.2% | -5.7% | -4.6% | $245 missed | ✗ |
| 2025-11-07 | UBS | Neutral → Neutral | maintained | True hold · target +0% | $219.16 | -5.2% | +1.8% | +2.2% | -0.1% | $220 hit | not graded |
| 2025-11-05 | Piper Sandler | Overweight → Overweight | reiterated | Bullish | $216.77 | -5.8% | +4.3% | +1.6% | +4.1% | $289 missed | ✓ |
| 2025-11-03 | Citigroup | Neutral → Neutral | maintained | Leans bullish · Neutral, target +10% | $211.96 | -9.4% | +8.6% | +8.2% | +6.5% | $235 hit | ✓ |
| 2025-11-03 | JPMorgan | Overweight → Overweight | maintained | Bullish | $211.96 | -9.4% | +8.6% | +8.2% | +6.5% | $260 missed | ✓ |
| 2025-10-20 | Guggenheim | Buy → Buy | maintained | Bullish | $232.06 | +4.3% | +0.4% | -2.3% | -7.8% | $242 missed | ✓ |
| 2025-10-17 | Raymond James | Outperform → Outperform | reiterated | Bullish | $229.57 | +4.0% | +1.9% | -2.6% | -5.6% | $250 missed | ✓ |
| 2025-10-10 | Piper Sandler | Overweight → Overweight | maintained | Bullish | $230.50 | — | -5.1% | -3.3% | -2.8% | $284 missed | ✗ |
| 2025-10-09 | Cantor Fitzgerald | Overweight → Overweight | maintained | Bullish | $230.69 | — | -5.2% | -3.3% | +1.2% | $250 missed | ✗ |
| 2025-10-03 | Bank of America | Neutral → Neutral | maintained | True hold · target +7% | $233.91 | — | -9.4% | -4.1% | -2.0% | $251 missed | not graded |
| 2025-10-01 | HSBC | Buy → Hold | downgrade | Bearish · cut to Hold | $244.38 | — | -10.8% | -7.9% | -6.0% | — | ✓ |
| 2025-09-22 | Evercore ISI Group | Outperform → Outperform | maintained | Bullish | $222.59 | — | +2.7% | +6.2% | +2.4% | $222 hit | ✓ |
| 2025-09-17 | Berenberg | Hold → Buy | upgrade | Bullish | $220.81 | — | +4.0% | +6.0% | +1.3% | $270 missed | ✓ |
| 2025-09-16 | JPMorgan | Overweight → Overweight | maintained | Bullish | $216.26 | — | +4.9% | +8.2% | +5.2% | $235 hit | ✓ |
| 2025-09-15 | Cantor Fitzgerald | Overweight → Overweight | maintained | Bullish | $217.61 | — | +4.0% | +6.8% | +4.5% | $245 missed | ✓ |
Also in Pharma
Interactive version with the price chart and target overlay: Scorecard tab on the dashboard. All covered names: index.
How the grading works
Every sell-side rating change from the last 365 days is priced the day it lands and checked again 30, 60 and 90 days later. A call is a hit when the stock moved in the called direction at 30 days. Buy- and Sell-side ratings call their own direction. A Hold is read, not waved through: a downgrade to Hold is graded as a bearish call and an upgrade to Hold as a bullish one, and a maintained Hold whose price target sits 10%+ above the price leans bullish (10%+ below, leans bearish) and is graded that way. A Hold with a target close to the price is a true Hold and is not graded at all. Every call with a price target also gets a target check 90 days later: hit (reached it or within 5%), close (covered at least half the distance) or missed. A firm's accuracy on a single name prints only after 4 scored calls, and a firm gets its own page only after 10 scored calls across every covered name — below that a percentage is noise. "Run before the call" is the stock's move over the 30 calendar days before the rating landed. Data: Yahoo Finance rating history and daily closes, rebuilt each morning. Nothing on this page is advice.
Get the 7 AM brief
The AM take, today's docket and the Street's calls — one email, weekdays, before the open.